Carregant...
Type 2 innate lymphoid cells impede IL-33-mediated tumor suppression
Although a number of studies have recently explored the contribution of the adaptive immunity in interleukin 33 (IL-33)-mediated antitumor effects, innate immune involvement has been poorly characterized. Utilizing Rag1(−/−) mice (lacking T and B lymphocytes), we show here that either systemic admin...
Guardat en:
| Publicat a: | J Immunol |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6264920/ https://ncbi.nlm.nih.gov/pubmed/30373846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1800173 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|